1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) is sponsored by National Institute on Aging (NIA) (NIH).
This Notice of Funding Opportunity (NOFO) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities.
Supported projects will be expected to enable future studies of complex nervous system development, function, and aging in healthy and disease states.
Get alerted about grants like this
Save a search for “National Institute on Aging (NIA) (NIH)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Eligible organizations include a wide range of institutions, including universities, colleges, small businesses, and non-profits. Confirm the full requirements in the official notice before applying.
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) is funded by National Institute on Aging (NIA) (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Pilot Program | Animal Models for the Social Dimensions of Health and Aging Research Network is sponsored by National Institute on Aging (NIA) (NIH). This program supports pilot and feasibility projects focused on animal models or comparative studies relevant to understanding the social determinants of health and aging, aiming to generate preliminary data for future K- or R-type NIH grant applications.
Analytical and Clinical Validation of Biomarkers for Alzheimer's Disease (AD) and AD-Related Dementias (ADRDs) is sponsored by National Institute on Aging (NIA) (NIH). This funding opportunity supports the analytical and clinical validation of biomarkers for Alzheimer's Disease (AD) and AD-Related Dementias (ADRDs). The NIA is committed to advancing research in the identification, development, and validation of biomarkers for AD/ADRD.
NIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleNIH committed $402 million across 601 multiyear-funded grants in the first eight months of FY 2026 — more than four times the pace of two years ago. The mechanism front-loads obligations into a single fiscal year, leaving less budget for new project starts and squeezing FY 2026 success rates. What researchers and institutions should be doing now.
Read articlePAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read article